A A A
OPB logo

Non-communicable Disease Prevention: Best Buys, Wasted Buys and Contestable Buys
More info and resources at: https://www.openbookpublishers.com/product/1113

Notes on Contributors

Thunyarat Anothaisintawee, MD., Ph.D., is a Family Physician. She holds a Ph.D. in Clinical Epidemiology and has worked as a faculty staff member at the Department of Family Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand. She is an expert in systematic reviews and meta-analysis and published several papers about the association between sleep factors and risk of developing diabetes mellitus in international medical journals. Currently, she is conducting the Prediabetes cohort study in Thailand. This cohort aims to investigate the association between sleep factors, eating habits, level of physical activity, genetic factors and risk of developing diabetes mellitus and chronic kidney disease in prediabetes people in Thailand.

Rachel A. Archer, M.P.H., is a Project Associate at the Health Intervention and Technology Assessment Program (HITAP). Her work focuses on health system strengthening and supporting evidence-informed health policy making in low- and middle-income countries (LMICs). She is the focal point at HITAP for the Total Systems Effectiveness (TSE) project, an approach to strengthen vaccine decision-making in LMICs, and she currently leads the PMAC Commissioned Work project. Rachel has also supported capacity-building activities for Indonesia, Kenya and The Philippines. Rachel holds a Master’s degree in Public Health from the University of Sheffield and a Bachelor of Arts in International Development from the University of Leeds. Whilst studying, she interned with various non-profit organizations across East and West Africa. For her Master’s thesis, Rachel collaborated with a non-profit to investigate the trend towards teenage pregnancy in Luwero District, Uganda, through an intersectional framework. She was awarded the Carpenter Prize for Best Dissertation.

Rachel L. Bacon, M.P.H., is the Project Manager for global health initiatives at the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies (ICRHPS) at Tufts Medical Center. Rachel is a public health professional with knowledge and applied experience in global health, reproductive health, health economics, health systems strengthening, population health management, clinical business management and quality improvement. She has a strong cross-cultural work history, with consulting experience developed internationally within the United States, Sub-Saharan Africa, Europe and the Asia Pacific. She is a member of the Consortium of Universities for Global Health (CUGH), the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the Institute for Health Care Improvement (IHI). She is also a trained labor and delivery birth doula with the Doula Organization of North America (DONA). Rachel holds a Master’s of Public Health from Boston University and a Bachelor of Arts in Anthropology from the University of New Hampshire.

Tazeem Bhatia, MPhil., MD., MRCGP, is a Public Health and Primary Care physician with twenty years’ experience of medical and public health practice in England, Myanmar, Afghanistan, Tajikistan and India. She has extensive expertise in the public health approach and tackling the wider determinants of health; community engagement and primary care; Universal Health Coverage (UHC) and models of social protection; and communicable and non-communicable disease (NCD) systems in high and low-income settings. She has conducted national level service and impact evaluations and sector wide health needs assessments, influencing senior leaders at a strategic level. She has worked in diverse environments and resource settings, from NGOs and think tanks, to Local Government, the NHS and UK Civil Service. Tazeem currently leads Public Health England’s global engagement on non-communicable disease with a focus on obesity. This includes advocating through evidence generation for action on the upstream social determinants of health.

Jesse B. Bump, M.P.H, Ph.D., is Executive Director of the Takemi Program in International Health and Lecturer on Global Health Policy in the Department of Global Health and Population at the Harvard T. H. Chan School of Public Health. He leads the global health field of study in the Master of Public Health degree and teaches on the political economy of global health. His research focuses on the intellectual ecology of global health, examining the historical, political and economic forces that are among the most fundamental determinants of ill health, and the most significant contextual factors that shape institutions and the approaches they embrace. This work addresses major themes in global health history and in the political economy of global health to analyze these macro forces and develop strategies for navigating solutions within them.

Kalipso Chalkidou, MD., Ph.D., is the Director of Global Health Policy and a Senior Fellow at the Center for Global Development, based in London and a Professor of Practice in Global Health at Imperial College London. Her work concentrates on helping governments build technical and institutional capacity for using evidence to inform health policy as they move towards Universal Healthcare Coverage. She is interested in how local information, local expertise and local institutions can drive scientific and legitimate healthcare resource allocation decisions. She has been involved in the Chinese rural health reforms and in national health reform projects in Colombia, Turkey and the Middle East, working with the World Bank, the Pan American Health Organization (PAHO), the Department for International Development (DFID) and the Inter-American Development Bank (IDB), as well as national governments. Between 2007 and 2008, she spent a year at the Johns Hopkins School of Public Health, as a Harkness fellow in Health Policy and Practice, studying how comparative effectiveness research can inform policy and US government drug pricing policies.

Kalipso led the establishment of NICE International, which she ran for eight years, and, more recently, of the international Decision Support Initiative (iDSI) which she directs and which is a multi-million, multi-country network working towards better health around the world through evidence-informed spending in healthcare in low to middle income countries. IDSI is funded by the Bill and Melinda Gates Foundation, the UK’s Department for International Development and the Rockefeller Foundation and is currently involved in national reform projects in China, India, Vietnam, Ghana, Indonesia and South Africa working together with key organizations such as the Thai Health Intervention and Technology Assessment Program (HITAP), the US Center for Global Development and PRICELESS, at Wits University in South Africa.

Anthony J. Culyer, Ph.D., is Emeritus Professor of Economics at the University of York (England), Senior Fellow at the Institute of Health Policy, Management and Evaluation at the University of Toronto (Canada) and Visiting Professor at Imperial College London. He is Chair of the Board of the international Decision Support Initiative (iDSI). He was the founding Organizer of the Health Economists’ Study Group. For thirty-three years he was the founding Co-Editor, with Joe Newhouse at Harvard, of Journal of Health Economics. He was founding Vice Chair of the National Institute for Health and Care Excellence (NICE) until 2003. He is Editor-in-Chief of the online Encyclopaedia of Health Economics. For many years he was chair of the Department of Economics & Related Studies at York and, for six of them, was also deputy vice-chancellor. He has published widely, mostly in health economics.

He is a Founding Fellow of the Academy of Medical Sciences, an Honorary Fellow of the Royal College of Physicians of London and an Honorary Member of the Finnish Society for Health Economics (2013). He holds an honorary doctorate from the Stockholm School of Economics and is a Commander of the British Empire (CBE). He has been a member or chaired many policy committees and boards in the UK and Canada including authoring the 1994 reforms of NHS Research and Development and being a director of the Canadian Agency for Drugs and Technologies in Health (CADTH).

David D. Kim, Ph.D., is an Assistant Professor of Medicine at Tufts University School of Medicine and a Program Director of the CEA Registry at the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies (ICRHPS) at Tufts Medical Center. As a health economist, he has been passionate about generating the best available economic evidence to inform health care decisions and public health policies through mathematical modeling. His primary research focuses on developing disease simulation models; improving methodology in economic evaluation and research prioritization; understanding health and economic consequences of health policies; and examining access to and utilization of cost-effective health interventions. He has developed several disease models for hepatitis C, alcohol use disorders, diabetes, cancer and cardiovascular diseases. Also, as a lead author of the worked example included in the Second Edition of Cost-Effectiveness in Health and Medicine, he conducted a cost-effectiveness analysis to reflect the comprehensive guidelines and recommendations. David received his doctorate in Health Economics at the University of Washington and his Master’s degree in Biostatistics from the University of Michigan.

Adam Elshaug, M.P.H., Ph.D., is a researcher specializing in the calculation of low-value care and a policy advisor on approaches to reducing waste to optimize value in health care. He is Professor of Health Policy and Co-Director of the Menzies Centre for Health Policy (MCHP) at The University of Sydney, Australia and is a Visiting Fellow with the USC-Brookings Schaeffer Initiative for Health Policy at The Brookings Institution in the USA. Professor Elshaug has numerous committee and Board appointments, including as a Ministerial appointee to the (Australian) Medicare Benefits Schedule (MBS) Review Taskforce. This is a five-year process to review Australia’s entire Medicare fee-for-service system utilizing Health Technology Assessment (HTA) principles and processes. Professor Elshaug was a 2010–2011 Commonwealth Fund Harkness Fellow based at the US Agency for Healthcare Research and Quality (AHRQ). From mid-2011 to mid-2013, he served as the National Health and Medical Research Council (NHMRC) Sidney Sax Fellow in Harvard Medical School’s Department of Health Care Policy. He is the recipient of numerous research awards and has published over 130 technical reports and peer review articles with first-author publications in journals such as The New England Journal of Medicine, BMJ and Journal of the American Medical Association. Professor Elshaug was Co-Lead of 2017 ‘Right Care’ Series of papers in The Lancet.

Wanrudee Isaranuwatchai, Ph.D., is a Senior Researcher at the Health Intervention and Technology Assessment Program (a part of the Ministry of Public Health) in Bangkok, Thailand, a Director at the Centre for Excellence in Economic Analysis Research of St. Michael’s Hospital and a Senior Health Economist at the Canadian Centre for Applied Research in Cancer Control in Canada. She is also an Assistant Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto. Her research focuses on how to apply economic evaluation in the real world setting as well as how to advance methods in economic evaluation. She has experience conducting economic evaluations using person-level data and decision modelling. She has collaborated with researchers and decision-makers in various areas to help communicate the value of health initiatives using economic evidence. Dr. Isaranuwatchai is dedicated to promoting the use of evidence in healthcare decision making.

Melitta Jakab, M.Sc., Ph.D., is a senior health economist at the WHO Barcelona Office for Health Systems Strengthening. She has twenty years of experience in health system strengthening, health financing, policy analysis and education in global health. Her work includes advising WHO Member States on health financing policy design and implementation, in particular in Moldova, Kazakhstan, Kyrgyzstan, Tajikistan, Turkey, Ukraine and Uzbekistan. She has been leading a multidisciplinary work program on the Health System Response to NCDs. She has been co-director of the Barcelona Courses on Health Systems Strengthening and Health Financing. She is co-editor of Health Systems Respond to NCDs: Time for Ambition (Jakab, Farrington, Borgermans, Mantingh, WHO Regional Office for Europe 2018) and of Implementing Health Financing Reform: Lessons from Countries in Transition (Kutzin, Cashin and Jakab, European Observatory, 2010). She has a PhD from Harvard University and M.Sc. in Health Policy for the Harvard School of Public Health.

Sumithra Krishnamurthy, M.P.H., has a particular interest in the political and social implications of NCDs for vulnerable populations, with an emphasis on access to services. Sumithra holds an M.P.H. in Global Health from the Harvard T. H. Chan School of Public Health and received her Bachelor’s degree in International Development from the University of Sussex in the UK. Her current research focuses on the political economy of NCDs from a global perspective. Sumithra has previously served at the United Nations Entity for Gender Equality and the Empowerment of Women (UN Women) as well as various civil society organizations in support of human rights and health in the UK, Mexico and Rwanda. She has also supported national health systems strengthening projects through consultancies in Mexico and Burkina Faso.

Alia Luz, M.Sc., works as a Project Associate with the management and research team of the international unit at Health Intervention and Technology Assessment Program (HITAP). She provides technical support in international and local economic evaluation projects, as well as administrative coordination for the organization’s regional and country projects. Her portfolio of work includes management of HITAP projects in the Philippines, as well as the Guide to Economic Analysis and Research (GEAR) online resource. In 2018, she received her Masters of Science (M.Sc.) in Health Policy, Planning and Financing (HPPF) from both the London School of Hygiene and Tropical Medicine (LSHTM) and the London School of Economics (LSE). Alia graduated from Bryn Mawr College in 2013 with a degree in economics. Post-graduation, she worked in Liberia on renewable energy economics for a project funded by the United States Agency for International Development (USAID).

Ryota Nakamura, M.A., Ph.D., is an Associate Professor based in the Hitotsubashi Institute for Advanced Study (HIAS), Hitotsubashi University. He also serves as a Visiting Associate Professor at the Institute of Statistical Mathematics. He is an applied microeconomist specializing in health. He holds a B.A. and an M.A. in Economics from Kyoto University and a Ph.D. in Economics from the University of York in the UK. Prior to joining Hitotsubashi University in 2016, he held positions at the University of East Anglia and the University of York. His research interests include empirical and theoretical investigations of health-related behavior, as well as of healthcare systems to inform national and international public health policies, using a wide range of research methods including micro-econometric analysis of observational data e.g., impact evaluation), economic experiment, modelling and evidence synthesis.

Peter J. Neumann, Sc.D., is Director of the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center and Professor of Medicine at Tufts University School of Medicine. He is the Founder and Director of the Cost-Effectiveness Analysis Registry. Dr. Neumann has written widely on clinical and economic evidence and on regulatory and reimbursement issues. He served as co-chair of the 2nd Panel on Cost-Effectiveness in Health and Medicine. He is the author or co-author of over 250 papers in medical literature, the author of Using Cost-Effectiveness Analysis to Improve Health Care (Oxford University Press, 2005) and co-editor of Cost-Effectiveness in Health and Medicine, 2nd Edition (Oxford University Press, 2016). Dr. Neumann has served as President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). He is a member of the editorial advisory board of Health Affairs and the health policy advisory board for the Congressional Budget Office. He has held several policy positions in Washington, including Special Assistant to the Administrator at the Health Care Financing Administration. He received his doctorate in health policy and management from Harvard University.

Waranya Rattanavipapong, M.Sc., joined Health Intervention and Technology Assessment Program (HITAP) in February 2010. She gained her Master’s degree in Health Economics and Decision Modelling from the University of Sheffield in 2014. She has strong expertise in health economic evaluations and has been involved in several research projects to support the Thai government as well as the public agencies in Bhutan, Indonesia, India and Vietnam.

Manushi Sharma, M.B.A., is an International Cooperation Officer at the Health Intervention and Technology Assessment Program (HITAP). She is a pharmacist by training with a Master’s in Business Management (M.B.A.). Previously, she worked with the Public Health Foundation of India with the health-economics and financing group. In the past, as a part of HITAP international unit (HIU), she has managed the iDSI Indonesia workstream. Currently, she is leading the monitoring and evaluation for all projects under HIU along with networking activities.

Arisa Shichijo, M.P.P., joined the project as a chapter team member. She received a B.A. in Law and Political science from Kyoto University and she is a second-year Master’s student at the School of International and Public Policy Hitotsubashi University. Her main field of research is health economics with a special focus on the process of policymaking and implementations in health-related areas and empirical analysis to inform public health interventions. She also completed a one-year exchange at McGill University, with a focus on Health Policy. She is now a Research Assistant at the Hitotsubashi Institute for Advanced Study (HIAS).

Peter C. Smith, Ph.D., is Emeritus Professor of Health Policy at Imperial College London and Honorary Professor of Health Economics, University of York. He is a mathematics graduate from the University of Oxford, with previous appointments at the University of Cambridge and the University of York, where he was Director of the Centre for Health Economics. His main research interest is in the economics of health, and his recent work has focused mainly on the financing and efficiency of health systems in low- and middle-income countries. Peter has published over 150 academic articles and twelve books, and has advised many governments and international agencies, including the World Health Organization, the International Monetary Fund, the Global Fund, the World Bank, the European Commission and the Organization for Economic Cooperation and Development.

Yot Teerawattananon, MD., Ph.D., is the founding leader of the Health Intervention and Technology Assessment Program (HITAP), which is a semi-autonomous research institute of Thailand’s Ministry of Public Health. The works of HITAP have been used to inform policy decisions regarding the adoption of medicines, medical devices, health promotion and disease prevention programmes under the Universal Health Coverage Scheme and the national pharmaceutical reimbursement list, the National List of Essential Medicines. Recently, he joins the National University of Singapore as a visiting professor at Saw Swee Hock School of Public Health as well as is the Executive Board of the international Decision Support Initiative (iDSI). He has published more than 140 peer-reviewed journal articles and provided technical support on HTA capacity building in Asia and Africa. He is also one of the founders of HTAsiaLink, a regional network comprising governmental health technology assessment agencies in the Asia and Pacific region.